These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 22351068)
1. Synaptic pathology of Down syndrome. Garner CC; Wetmore DZ Adv Exp Med Biol; 2012; 970():451-68. PubMed ID: 22351068 [TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder. Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865 [TBL] [Abstract][Full Text] [Related]
3. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443 [TBL] [Abstract][Full Text] [Related]
4. Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome. Morice E; Farley S; Poirier R; Dallerac G; Chagneau C; Pannetier S; Hanauer A; Davis S; Vaillend C; Laroche S Neurobiol Dis; 2013 Oct; 58():156-68. PubMed ID: 23742761 [TBL] [Abstract][Full Text] [Related]
5. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. Kleschevnikov AM; Belichenko PV; Villar AJ; Epstein CJ; Malenka RC; Mobley WC J Neurosci; 2004 Sep; 24(37):8153-60. PubMed ID: 15371516 [TBL] [Abstract][Full Text] [Related]
6. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. Belichenko NP; Belichenko PV; Kleschevnikov AM; Salehi A; Reeves RH; Mobley WC J Neurosci; 2009 May; 29(18):5938-48. PubMed ID: 19420260 [TBL] [Abstract][Full Text] [Related]
7. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome. Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201 [TBL] [Abstract][Full Text] [Related]
8. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. Siarey RJ; Villar AJ; Epstein CJ; Galdzicki Z Neuropharmacology; 2005 Jul; 49(1):122-8. PubMed ID: 15992587 [TBL] [Abstract][Full Text] [Related]
9. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome. Siarey RJ; Stoll J; Rapoport SI; Galdzicki Z Neuropharmacology; 1997; 36(11-12):1549-54. PubMed ID: 9517425 [TBL] [Abstract][Full Text] [Related]
10. Chromosome 21 and down syndrome: from genomics to pathophysiology. Antonarakis SE; Lyle R; Dermitzakis ET; Reymond A; Deutsch S Nat Rev Genet; 2004 Oct; 5(10):725-38. PubMed ID: 15510164 [TBL] [Abstract][Full Text] [Related]
12. Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome. Chang P; Bush D; Schorge S; Good M; Canonica T; Shing N; Noy S; Wiseman FK; Burgess N; Tybulewicz VLJ; Walker MC; Fisher EMC Cell Rep; 2020 Jan; 30(4):1152-1163.e4. PubMed ID: 31995755 [TBL] [Abstract][Full Text] [Related]
13. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Li J; Pelletier MR; Perez Velazquez JL; Carlen PL Mol Cell Neurosci; 2002 Feb; 19(2):138-51. PubMed ID: 11860268 [TBL] [Abstract][Full Text] [Related]
14. Age-dependent alterations of long-term synaptic plasticity in thyroid-deficient rats. Vara H; Muñoz-Cuevas J; Colino A Hippocampus; 2003; 13(7):816-25. PubMed ID: 14620877 [TBL] [Abstract][Full Text] [Related]
15. [Comprehensive Analyses of Molecules with Altered Expression in the Brain of a Mouse Model of Down Syndrome for Identification of Pharmacotherapeutic Targets]. Ishihara K Yakugaku Zasshi; 2017; 137(7):807-810. PubMed ID: 28674291 [TBL] [Abstract][Full Text] [Related]
16. Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome. Blanchard J; Bolognin S; Chohan MO; Rabe A; Iqbal K; Grundke-Iqbal I J Neuropathol Exp Neurol; 2011 Dec; 70(12):1070-9. PubMed ID: 22082658 [TBL] [Abstract][Full Text] [Related]
17. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197 [TBL] [Abstract][Full Text] [Related]
18. Gene-dosage effects in Down syndrome and trisomic mouse models. Gardiner K Genome Biol; 2004; 5(10):244. PubMed ID: 15461808 [TBL] [Abstract][Full Text] [Related]
19. Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Yu T; Liu C; Belichenko P; Clapcote SJ; Li S; Pao A; Kleschevnikov A; Bechard AR; Asrar S; Chen R; Fan N; Zhou Z; Jia Z; Chen C; Roder JC; Liu B; Baldini A; Mobley WC; Yu YE Brain Res; 2010 Dec; 1366():162-71. PubMed ID: 20932954 [TBL] [Abstract][Full Text] [Related]
20. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K Cereb Cortex; 2010 May; 20(5):1131-43. PubMed ID: 19710359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]